ROYALTY PHARMA PLC- CL A(NASDAQ:RPRX) stock News

RPRX Latest News, Press Relases and Analysis

All

Press Releases

2 days ago - By: Royalty Pharma plc

Royalty Pharma Declares Fourth Quarter 2025 Dividend

2 days ago - By: Royalty Pharma plc

Royalty Pharma Declares Fourth Quarter 2025 Dividend

9 days ago - By: Royalty Pharma plc

Royalty Pharma to Announce Third Quarter 2025 Financial Results on November 5, 2025

9 days ago - By: Royalty Pharma plc

Royalty Pharma to Announce Third Quarter 2025 Financial Results on November 5, 2025

a month ago - By: Benzinga

How Do Investors Really Feel About Royalty Pharma?

2 months ago - By: Benzinga

Here's How Much $1000 Invested In Royalty Pharma 15 Years Ago Would Be Worth Today

20 days ago - By: Royalty Pharma plc

Royalty Pharma Appoints Dr. Ted W. Love As Lead Independent Director

20 days ago - By: Royalty Pharma plc

Royalty Pharma Appoints Dr. Ted W. Love As Lead Independent Director

a month ago - By: Royalty Pharma plc

Royalty Pharma to Present at Bernstein’s 2nd Annual Healthcare Forum

a month ago - By: Royalty Pharma plc

Royalty Pharma to Present at Bernstein’s 2nd Annual Healthcare Forum

a month ago - By: Yahoo Finance

Royalty Pharma plc (RPRX) Reports 20% Portfolio Growth, Posts $727M in Q2 Receipts

a month ago - By: Royalty Pharma plc

Royalty Pharma Investor Day Highlights Strong Growth Outlook and Company’s Plans to Drive Value Creation

a month ago - By: Royalty Pharma plc

Royalty Pharma Investor Day Highlights Strong Growth Outlook and Company’s Plans to Drive Value Creation

a month ago - By: Royalty Pharma plc

Royalty Pharma Announces Release of Deloitte’s Report on the Biopharma Royalty Market

a month ago - By: Royalty Pharma plc

Royalty Pharma Announces Release of Deloitte’s Report on the Biopharma Royalty Market

a month ago - By: Royalty Pharma plc

Royalty Pharma to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference

a month ago - By: Royalty Pharma plc

Royalty Pharma to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference

2 months ago - By: Royalty Pharma plc

Royalty Pharma Announces Pricing of $2.0 Billion of Senior Unsecured Notes

2 months ago - By: Royalty Pharma plc

Royalty Pharma Announces Pricing of $2.0 Billion of Senior Unsecured Notes

2 months ago - By: Royalty Pharma plc

Royalty Pharma and Zenas BioPharma Enter Into Obexelimab Funding Agreement for Up to $300 Million

2 months ago - By: Royalty Pharma plc

Royalty Pharma and Zenas BioPharma Enter Into Obexelimab Funding Agreement for Up to $300 Million

2 months ago - By: Zenas BioPharma - Mentions: ZBIO

Zenas BioPharma and Royalty Pharma Enter into Obexelimab Funding Agreement for up to $300 Million

2 months ago - By: Yahoo Finance - Mentions: AMGN PAA VG AU

Royalty Pharma (RPRX) Strengthens Pipeline With New Oncology Royalty Purchase

2 months ago - By: Yahoo Finance - Mentions: GILD RVMD

Royalty Pharma plc (RPRX) Strikes $2B Partnership with Revolution Medicines

2 months ago - By: Yahoo Finance - Mentions: AMGN

Royalty Pharma buys BeOne stake in Amgen lung cancer drug sales

2 months ago - By: Royalty Pharma plc

Royalty Pharma to Acquire Royalty Interest in Amgen’s Imdelltra for up to $950 Million

2 months ago - By: Royalty Pharma plc

Royalty Pharma to Acquire Royalty Interest in Amgen’s Imdelltra for up to $950 Million

2 months ago - By: Royalty Pharma plc

Henry Fernandez Steps Down from Royalty Pharma's Board of Directors

2 months ago - By: Royalty Pharma plc

Henry Fernandez Steps Down from Royalty Pharma's Board of Directors

2 months ago - By: Yahoo Finance - Mentions: MS PFE

ROYALTY PHARMA PLC- CL A (RPRX) Stock News

RPRX Latest News, Press Relases and Analysis

Royalty Pharma Declares Fourth Quarter 2025 Dividend

Royalty Pharma Declares Fourth Quarter 2025 Dividend

Royalty Pharma to Announce Third Quarter 2025 Financial Results on November 5, 2025

Royalty Pharma to Announce Third Quarter 2025 Financial Results on November 5, 2025

How Do Investors Really Feel About Royalty Pharma?

Here's How Much $1000 Invested In Royalty Pharma 15 Years Ago Would Be Worth Today

Royalty Pharma Appoints Dr. Ted W. Love As Lead Independent Director

Royalty Pharma Appoints Dr. Ted W. Love As Lead Independent Director

Royalty Pharma to Present at Bernstein’s 2nd Annual Healthcare Forum

Royalty Pharma to Present at Bernstein’s 2nd Annual Healthcare Forum

Royalty Pharma plc (RPRX) Reports 20% Portfolio Growth, Posts $727M in Q2 Receipts

Royalty Pharma Investor Day Highlights Strong Growth Outlook and Company’s Plans to Drive Value Creation

Royalty Pharma Investor Day Highlights Strong Growth Outlook and Company’s Plans to Drive Value Creation

Royalty Pharma Announces Release of Deloitte’s Report on the Biopharma Royalty Market

Royalty Pharma Announces Release of Deloitte’s Report on the Biopharma Royalty Market

Royalty Pharma to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference

Royalty Pharma to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference

Royalty Pharma Announces Pricing of $2.0 Billion of Senior Unsecured Notes

Royalty Pharma Announces Pricing of $2.0 Billion of Senior Unsecured Notes

Royalty Pharma and Zenas BioPharma Enter Into Obexelimab Funding Agreement for Up to $300 Million

Royalty Pharma and Zenas BioPharma Enter Into Obexelimab Funding Agreement for Up to $300 Million

Zenas BioPharma and Royalty Pharma Enter into Obexelimab Funding Agreement for up to $300 Million

Royalty Pharma (RPRX) Strengthens Pipeline With New Oncology Royalty Purchase

Royalty Pharma plc (RPRX) Strikes $2B Partnership with Revolution Medicines

Royalty Pharma buys BeOne stake in Amgen lung cancer drug sales

Royalty Pharma to Acquire Royalty Interest in Amgen’s Imdelltra for up to $950 Million

Royalty Pharma to Acquire Royalty Interest in Amgen’s Imdelltra for up to $950 Million

Henry Fernandez Steps Down from Royalty Pharma's Board of Directors

Henry Fernandez Steps Down from Royalty Pharma's Board of Directors

Morgan Stanley Maintains a Buy Rating on Royalty Pharma Plc (RPRX) With a $55 PT